Profile of:

Clementina López-Medina


Full name: Clementina López-Medina

Current country: Spain

Membership level: Full

Type of membership: Member

Number of publications: 15

Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study (2023)
https://pubmed.ncbi.nlm.nih.gov/36516482/

Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries (2023)
https://pubmed.ncbi.nlm.nih.gov/37734875/

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data (2023)
https://pubmed.ncbi.nlm.nih.gov/37291655/

Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry (2023)
https://pubmed.ncbi.nlm.nih.gov/36639793/

Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with Ankylosing Spondylitis. Two-year follow-up in REGISPONSER-AS. (2022)
https://pubmed.ncbi.nlm.nih.gov/35027249/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Which factors explain the patient global assessment in patients with ankylosing spondylitis? A hierarchical cluster analysis on REGISPONSER-AS (2021)
https://pubmed.ncbi.nlm.nih.gov/34198145/

Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort. Ann Rheum Dis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31784451/

Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry. Rheumatology (Oxford) (2020)
https://pubmed.ncbi.nlm.nih.gov/32856083/

Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study. J Rheumatol (2020)
https://pubmed.ncbi.nlm.nih.gov/30988127/

Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open (2019)
https://pubmed.ncbi.nlm.nih.gov/31803500/

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort. Arthritis Res Ther (2019)
https://pubmed.ncbi.nlm.nih.gov/31171034/

Adherence to recommendations for the use of anti-tumour necrosis factor and its impact over 5 years of follow-up in axial spondyloarthritis. Rheumatology (Oxford) (2018)
https://pubmed.ncbi.nlm.nih.gov/29474666/

Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. Clin Rheumatol (2018)
https://pubmed.ncbi.nlm.nih.gov/29691772/

Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project (2018)
https://pubmed.ncbi.nlm.nih.gov/28754402/